{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:30:01Z","timestamp":1793205001269,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T00:00:00Z","timestamp":1198108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T00:00:00Z","timestamp":1198108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1038\/sj.leu.2405068","type":"journal-article","created":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T11:40:39Z","timestamp":1198150839000},"page":"487-495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":221,"title":["Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria"],"prefix":"10.1038","volume":"22","author":[{"given":"E","family":"Matutes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Oscier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Montalban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Callet-Bauchu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Felman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Iannitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mollejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Papadaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E D","family":"Remstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Salar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Thieblemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Traverse-Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Wotherspoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Coiffier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Piris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,20]]},"reference":[{"key":"BF2405068_CR1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00000478-199205000-00004","volume":"16","author":"C Schmid","year":"1992","unstructured":"Schmid C, Kirkham N, Diss T, Isaacson PG . Splenic marginal zone cell lymphoma. Am J Surg Pathol 1992; 16: 455\u2013466.","journal-title":"Am J Surg Pathol"},{"key":"BF2405068_CR2","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al. A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361\u20131392.","journal-title":"Blood"},{"key":"BF2405068_CR3","first-page":"148","volume":"36","author":"D Catovsky","year":"1999","unstructured":"Catovsky D, Matutes E . Splenic lymphoma with circulating villous lymphocytes\/splenic marginal-zone lymphoma. Semin Hematol 1999; 36: 148\u2013154.","journal-title":"Semin Hematol"},{"key":"BF2405068_CR4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3816\/CLM.2004.n.005","volume":"4","author":"L Arcaini","year":"2004","unstructured":"Arcaini L, Orlandi E, Scotti M, Brusamolino E, Passamonti F, Burcheri S et al. Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma. Clin Lymphoma 2004; 4: 250\u2013252.","journal-title":"Clin Lymphoma"},{"key":"BF2405068_CR5","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1182\/blood-2002-10-3230","volume":"102","author":"A Mele","year":"2003","unstructured":"Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo MG et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case\u2013control study. Blood 2003; 102: 996\u2013999.","journal-title":"Blood"},{"key":"BF2405068_CR6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3816\/CLM.2002.n.010","volume":"3","author":"C Thieblemont","year":"2002","unstructured":"Thieblemont C, Felman P, Berger F, Dumontet C, Arnaud P, Hequet O et al. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. Clin Lymphoma 2002; 3: 41\u201347.","journal-title":"Clin Lymphoma"},{"key":"BF2405068_CR7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1470-2045(03)00981-1","volume":"4","author":"C Thieblemont","year":"2003","unstructured":"Thieblemont C, Felman P, Callet-Bauchu E, Traverse-Glehen A, Salles G, Berger F et al. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol 2003; 4: 95\u2013103.","journal-title":"Lancet Oncol"},{"key":"BF2405068_CR8","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","volume":"107","author":"L Arcaini","year":"2006","unstructured":"Arcaini L, Lazzarino M, Colombo N, Burcheri S, Boveri E, Paulli M et al. Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood 2006; 107: 4643\u20134649.","journal-title":"Blood"},{"key":"BF2405068_CR9","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","volume":"100","author":"JI Chacon","year":"2002","unstructured":"Chacon JI, Mollejo M, Munoz E, Algara P, Mateo M, Lopez L et al. Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood 2002; 100: 1648\u20131654.","journal-title":"Blood"},{"key":"BF2405068_CR10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2141.1996.d01-1711.x","volume":"93","author":"X Troussard","year":"1996","unstructured":"Troussard X, Valensi F, Duchayne E, Garand R, Felman P, Tulliez M et al. Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC). Br J Haematol 1996; 93: 731\u2013736.","journal-title":"Br J Haematol"},{"key":"BF2405068_CR11","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/cncr.20596","volume":"101","author":"E Iannitto","year":"2004","unstructured":"Iannitto E, Ambrosetti A, Ammatuna E, Colosio M, Florena AM, Tripodo C et al. Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients. Cancer 2004; 101: 2050\u20132057.","journal-title":"Cancer"},{"key":"BF2405068_CR12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2141.2003.04165.x","volume":"120","author":"N Parry-Jones","year":"2003","unstructured":"Parry-Jones N, Matutes E, Gruszka-Westwood AM, Swansbury GJ, Wotherspoon AC, Catovsky D . Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients. Br J Haematol 2003; 120: 759\u2013764.","journal-title":"Br J Haematol"},{"key":"BF2405068_CR13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-0609.2005.00578.x","volume":"76","author":"E Iannitto","year":"2006","unstructured":"Iannitto E, Minardi V, Callea V, Stelitano C, Calvaruso G, Tripodo C et al. Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma. Eur J Haematol 2006; 76: 134\u2013140.","journal-title":"Eur J Haematol"},{"key":"BF2405068_CR14","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00000478-200110000-00007","volume":"25","author":"FI Camacho","year":"2001","unstructured":"Camacho FI, Mollejo M, Mateo MS, Algara P, Navas C, Hernandez JM et al. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases. Am J Surg Pathol 2001; 25: 1268\u20131276.","journal-title":"Am J Surg Pathol"},{"key":"BF2405068_CR15","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1182\/blood.V84.11.3828.bloodjournal84113828","volume":"84","author":"PG Isaacson","year":"1994","unstructured":"Isaacson PG, Matutes E, Burke M, Catovsky D . The histopathology of splenic lymphoma with villous lymphocytes. Blood 1994; 84: 3828\u20133834.","journal-title":"Blood"},{"key":"BF2405068_CR16","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1182\/blood.V83.6.1558.1558","volume":"83","author":"E Matutes","year":"1994","unstructured":"Matutes E, Morilla R, Owusu-Ankomah K, Houlihan A, Catovsky D . The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood 1994; 83: 1558\u20131562.","journal-title":"Blood"},{"key":"BF2405068_CR17","first-page":"1640","volume":"8","author":"E Matutes","year":"1994","unstructured":"Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640\u20131645.","journal-title":"Leukemia"},{"key":"BF2405068_CR18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2559.1996.d01-536.x","volume":"29","author":"V Franco","year":"1996","unstructured":"Franco V, Florena AM, Campesi G . Intrasinusoidal bone marrow infiltration: a possible hallmark of splenic lymphoma. Histopathology 1996; 29: 571\u2013575.","journal-title":"Histopathology"},{"key":"BF2405068_CR19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/1097-0142(20010115)91:2<294::AID-CNCR1001>3.0.CO;2-W","volume":"91","author":"V Franco","year":"2001","unstructured":"Franco V, Florena AM, Stella M, Rizzo A, Iannitto E, Quintini G et al. Splenectomy influences bone marrow infiltration in patients with splenic marginal zone cell lymphoma with or without villous lymphocytes. Cancer 2001; 91: 294\u2013301.","journal-title":"Cancer"},{"key":"BF2405068_CR20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1365-2141.2003.04449.x","volume":"122","author":"J Audouin","year":"2003","unstructured":"Audouin J, Le Tourneau A, Molina T, Camilleri-Broet S, Adida C, Comperat E et al. Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes. Br J Haematol 2003; 122: 404\u2013412.","journal-title":"Br J Haematol"},{"key":"BF2405068_CR21","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1365-2141.1999.01200.x","volume":"104","author":"H Mossafa","year":"1999","unstructured":"Mossafa H, Malaure H, Maynadie M, Valensi F, Schillinger F, Garand R et al. Persistent polyclonal B lymphocytosis with binucleated lymphocytes: a study of 25 cases. Groupe Francais d'Hematologie Cellulaire. Br J Haematol 1999; 104: 486\u2013493.","journal-title":"Br J Haematol"},{"key":"BF2405068_CR22","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood.V98.4.1182","volume":"98","author":"H Liu","year":"2001","unstructured":"Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi RA, Bearzi I et al. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 2001; 98: 1182\u20131187.","journal-title":"Blood"},{"key":"BF2405068_CR23","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000478-199510000-00005","volume":"19","author":"M Mollejo","year":"1995","unstructured":"Mollejo M, Menarguez J, Lloret E, Sanchez A, Campo E, Algara P et al. Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases. Am J Surg Pathol 1995; 19: 1146\u20131157.","journal-title":"Am J Surg Pathol"},{"key":"BF2405068_CR24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.pas.0000213419.08009.b0","volume":"31","author":"T Papadaki","year":"2007","unstructured":"Papadaki T, Stamatopoulos K, Belessi C, Pouliou E, Parasi A, Douka V et al. Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases. Am J Surg Pathol 2007; 31: 438\u2013446.","journal-title":"Am J Surg Pathol"},{"key":"BF2405068_CR25","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/1097-0142(197703)39:3<1146::AID-CNCR2820390320>3.0.CO;2-X","volume":"39","author":"RC Braylan","year":"1977","unstructured":"Braylan RC, Long JC, Jaffe ES, Greco FA, Orr SL, Berard CW . Malignant lymphoma obscured by concomitant extensive epithelioid granulomas: report of three cases with similar clinicopathologic features. Cancer 1977; 39: 1146\u20131155.","journal-title":"Cancer"},{"key":"BF2405068_CR26","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/00000478-200012000-00001","volume":"24","author":"JP Van Huyen","year":"2000","unstructured":"Van Huyen JP, Molina T, Delmer A, Audouin J, Le Tourneau A, Zittoun R et al. Splenic marginal zone lymphoma with or without plasmacytic differentiation. Am J Surg Pathol 2000; 24: 1581\u20131592.","journal-title":"Am J Surg Pathol"},{"key":"BF2405068_CR27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0046-8177(99)90031-X","volume":"30","author":"E Lloret","year":"1999","unstructured":"Lloret E, Mollejo M, Mateo MS, Villuendas R, Algara P, Martinez P et al. Splenic marginal zone lymphoma with increased number of blasts: an aggressive variant? Hum Pathol 1999; 30: 1153\u20131160.","journal-title":"Hum Pathol"},{"key":"BF2405068_CR28","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0145-2126(95)00165-4","volume":"20","author":"F Salomon-Nguyen","year":"1996","unstructured":"Salomon-Nguyen F, Valensi F, Troussard X, Flandrin G . The value of the monoclonal antibody, DBA44, in the diagnosis of B-lymphoid disorders. Leuk Res 1996; 20: 909\u2013913.","journal-title":"Leuk Res"},{"key":"BF2405068_CR29","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0046-8177(99)90031-X","volume":"30","author":"E Lloret","year":"1999","unstructured":"Lloret E, Mollejo M, Mateo MS, Villuendas R, Algara P, Martinez P et al. Splenic marginal zone lymphoma with increased number of blasts: an aggressive variant? Hum Pathol 1999; 30: 1153\u20131160.","journal-title":"Hum Pathol"},{"key":"BF2405068_CR30","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00000478-199707000-00005","volume":"21","author":"M Mollejo","year":"1997","unstructured":"Mollejo M, Lloret E, Menarguez J, Piris MA, Isaacson PG . Lymph node involvement by splenic marginal zone lymphoma: morphological and immunohistochemical features. Am J Surg Pathol 1997; 21: 772\u2013780.","journal-title":"Am J Surg Pathol"},{"key":"BF2405068_CR31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood.V93.1.226","volume":"93","author":"A Tierens","year":"1999","unstructured":"Tierens A, Delabie J, Michiels L, Vandenberghe P, De Wolf-Peeters C . Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. Blood 1999; 93: 226\u2013234.","journal-title":"Blood"},{"key":"BF2405068_CR32","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood.V85.6.1603.bloodjournal8561603","volume":"85","author":"D Zhu","year":"1995","unstructured":"Zhu D, Oscier DG, Stevenson FK . Splenic lymphoma with villous lymphocytes involves B cells with extensively mutated Ig heavy chain variable region genes. Blood 1995; 85: 1603\u20131607.","journal-title":"Blood"},{"key":"BF2405068_CR33","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood.V99.4.1299","volume":"99","author":"P Algara","year":"2002","unstructured":"Algara P, Mateo MS, Sanchez-Beato M, Mollejo M, Navas IC, Romero L et al. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood 2002; 99: 1299\u20131304.","journal-title":"Blood"},{"key":"BF2405068_CR34","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0046-8177(99)90010-2","volume":"30","author":"RN Miranda","year":"1999","unstructured":"Miranda RN, Cousar JB, Hammer RD, Collins RD, Vnencak-Jones CL . Somatic mutation analysis of IgH variable regions reveals that tumor cells of most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma, and some hairy cell leukemia are composed of memory B lymphocytes. Hum Pathol 1999; 30: 306\u2013312.","journal-title":"Hum Pathol"},{"key":"BF2405068_CR35","first-page":"470","volume":"90","author":"A Traverse-Glehen","year":"2005","unstructured":"Traverse-Glehen A, Davi F, Ben Simon E, Callet-Bauchu E, Felman P, Baseggio L et al. Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection. Haematologica 2005; 90: 470\u2013478.","journal-title":"Haematologica"},{"key":"BF2405068_CR36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0002-9440(10)61691-4","volume":"159","author":"R Marasca","year":"2001","unstructured":"Marasca R, Vaccari P, Luppi M, Zucchini P, Castelli I, Barozzi P et al. Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. Am J Pathol 2001; 159: 253\u2013261.","journal-title":"Am J Pathol"},{"key":"BF2405068_CR37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2119\/2005-00001.Stamatopoulos","volume":"10","author":"K Stamatopoulos","year":"2004","unstructured":"Stamatopoulos K, Belessi C, Papadaki T, Kalagiakou E, Stavroyianni N, Douka V et al. Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma. Mol Med 2004; 10: 89\u201395.","journal-title":"Mol Med"},{"key":"BF2405068_CR38","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2002-01-0169","volume":"100","author":"D Zhu","year":"2002","unstructured":"Zhu D, Orchard J, Oscier DG, Wright DH, Stevenson FK . V(H) gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo. Blood 2002; 100: 2659\u20132661.","journal-title":"Blood"},{"key":"BF2405068_CR39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0002-9440(10)64159-4","volume":"161","author":"DW Bahler","year":"2002","unstructured":"Bahler DW, Pindzola JA, Swerdlow SH . Splenic marginal zone lymphomas appear to originate from different B cell types. Am J Pathol 2002; 161: 81\u201388.","journal-title":"Am J Pathol"},{"key":"BF2405068_CR40","first-page":"286b","volume":"100","author":"DDZ Oscier","year":"2002","unstructured":"Oscier DDZ, Parker A, Mould S, Chapman RM, Orchard JA . Splenic marginal zone lymphoma and splenic lymphoma with villous lymphocytes\/a single disease entity. Blood 2002; 100: 286b.","journal-title":"Blood"},{"key":"BF2405068_CR41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2141.1993.tb03337.x","volume":"85","author":"DG Oscier","year":"1993","unstructured":"Oscier DG, Matutes E, Gardiner A, Glide S, Mould S, Brito-Babapulle V et al. Cytogenetic studies in splenic lymphoma with villous lymphocytes. Br J Haematol 1993; 85: 487\u2013491.","journal-title":"Br J Haematol"},{"key":"BF2405068_CR42","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1365-2141.1998.00764.x","volume":"101","author":"X Troussard","year":"1998","unstructured":"Troussard X, Mauvieux L, Radford-Weiss I, Rack K, Valensi F, Garand R et al. Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Francais d'Hematologie Cellulaire (GFHC) study. Br J Haematol 1998; 101: 712\u2013721.","journal-title":"Br J Haematol"},{"key":"BF2405068_CR43","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1182\/blood.V97.11.3552","volume":"97","author":"AM Gruszka-Westwood","year":"2001","unstructured":"Gruszka-Westwood AM, Hamoudi RA, Matutes E, Tuset E, Catovsky D . p53 abnormalities in splenic lymphoma with villous lymphocytes. Blood 2001; 97: 3552\u20133558.","journal-title":"Blood"},{"key":"BF2405068_CR44","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0002-9440(10)64140-5","volume":"158","author":"JM Hernandez","year":"2001","unstructured":"Hernandez JM, Garcia JL, Gutierrez NC, Mollejo M, Martinez-Climent JA, Flores T et al. Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics. Am J Pathol 2001; 158: 1843\u20131850.","journal-title":"Am J Pathol"},{"key":"BF2405068_CR45","first-page":"71","volume":"86","author":"F Sole","year":"2001","unstructured":"Sole F, Salido M, Espinet B, Garcia JL, Martinez Climent JA, Granada I et al. Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q. Haematologica 2001; 86: 71\u201377.","journal-title":"Haematologica"},{"key":"BF2405068_CR46","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/sj.leu.2403909","volume":"19","author":"E Callet-Bauchu","year":"2005","unstructured":"Callet-Bauchu E, Baseggio L, Felman P, Traverse-Glehen A, Berger F, Morel D et al. Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases. Leukemia 2005; 19: 1818\u20131823.","journal-title":"Leukemia"},{"key":"BF2405068_CR47","first-page":"31","volume":"88","author":"S Gazzo","year":"2003","unstructured":"Gazzo S, Baseggio L, Coignet L, Poncet C, Morel D, Coiffier B et al. Cytogenetic and molecular delineation of a region of chromosome 3q commonly gained in marginal zone B-cell lymphoma. Haematologica 2003; 88: 31\u201338.","journal-title":"Haematologica"},{"key":"BF2405068_CR48","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cancergencyto.2004.04.026","volume":"156","author":"CL Andersen","year":"2005","unstructured":"Andersen CL, Gruszka-Westwood A, Atkinson S, Matutes E, Catovsky D, Pedersen RK et al. Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization. Cancer Genet Cytogenet 2005; 156: 122\u2013128.","journal-title":"Cancer Genet Cytogenet"},{"key":"BF2405068_CR49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1365-2559.1998.00478.x","volume":"33","author":"MA Piris","year":"1998","unstructured":"Piris MA, Mollejo M, Campo E, Menarguez J, Flores T, Isaacson PG . A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma. Histopathology 1998; 33: 230\u2013239.","journal-title":"Histopathology"},{"key":"BF2405068_CR50","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1182\/blood.V90.10.4071","volume":"90","author":"MQ Du","year":"1997","unstructured":"Du MQ, Peng HZ, Dogan A, Diss TC, Liu H, Pan LX et al. Preferential dissemination of B-cell gastric mucosa-associated lymphoid tissue (MALT) lymphoma to the splenic marginal zone. Blood 1997; 90: 4071\u20134077.","journal-title":"Blood"},{"key":"BF2405068_CR51","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0002-9440(10)64988-7","volume":"156","author":"ED Remstein","year":"2000","unstructured":"Remstein ED, James CD, Kurtin PJ . Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol 2000; 156: 1183\u20131188.","journal-title":"Am J Pathol"},{"key":"BF2405068_CR52","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0046-8177(96)90093-3","volume":"27","author":"S Alkan","year":"1996","unstructured":"Alkan S, Ross CW, Hanson CA, Schnitzer B . Follicular lymphoma with involvement of the splenic marginal zone: a pitfall in the differential diagnosis of splenic marginal zone cell lymphoma. Hum Pathol 1996; 27: 503\u2013506.","journal-title":"Hum Pathol"},{"key":"BF2405068_CR53","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00000478-200304000-00014","volume":"27","author":"L Taddesse-Heath","year":"2003","unstructured":"Taddesse-Heath L, Pittaluga S, Sorbara L, Bussey M, Raffeld M, Jaffe ES . Marginal zone B-cell lymphoma in children and young adults. Am J Surg Pathol 2003; 27: 522\u2013531.","journal-title":"Am J Surg Pathol"},{"key":"BF2405068_CR54","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hon.762","volume":"23","author":"M Mollejo","year":"2005","unstructured":"Mollejo M, Camacho FI, Algara P, Ruiz-Ballesteros E, Garcia JF, Piris MA . Nodal and splenic marginal zone B cell lymphomas. Hematol Oncol 2005; 23: 108\u2013118.","journal-title":"Hematol Oncol"},{"key":"BF2405068_CR55","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1525-1578(10)60563-6","volume":"7","author":"TI George","year":"2005","unstructured":"George TI, Wrede JE, Bangs CD, Cherry AM, Warnke RA, Arber DA . Low-grade B-cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements. J Mol Diagn 2005; 7: 346\u2013351.","journal-title":"J Mol Diagn"},{"key":"BF2405068_CR56","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1182\/blood.V100.8.2996","volume":"100","author":"RF Schop","year":"2002","unstructured":"Schop RF, Kuehl WM, Van Wier SA, Ahmann GJ, Price-Troska T, Bailey RJ et al. Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood 2002; 100: 2996\u20133001.","journal-title":"Blood"},{"key":"BF2405068_CR57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2559.2002.01314.x","volume":"40","author":"M Mollejo","year":"2002","unstructured":"Mollejo M, Algara P, Mateo MS, Sanchez-Beato M, Lloret E, Medina MT et al. Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma? Histopathology 2002; 40: 22\u201330.","journal-title":"Histopathology"},{"key":"BF2405068_CR58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2559.2002.01314.x","volume":"40","author":"M Mollejo","year":"2002","unstructured":"Mollejo M, Algara P, Mateo MS, Sanchez-Beato M, Lloret E, Medina MT et al. Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma? Histopathology 2002; 40: 22\u201330.","journal-title":"Histopathology"},{"key":"BF2405068_CR59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/gcc.10142","volume":"36","author":"AM Gruszka-Westwood","year":"2003","unstructured":"Gruszka-Westwood AM, Hamoudi R, Osborne L, Matutes E, Catovsky D . Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes. Genes Chromosomes Cancer 2003; 36: 57\u201369.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2405068_CR60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.V76.1.157.157","volume":"76","author":"L Sainati","year":"1990","unstructured":"Sainati L, Matutes E, Mulligan S, de Oliveira MP, Rani S, Lampert IA et al. A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients. Blood 1990; 76: 157\u2013162.","journal-title":"Blood"},{"key":"BF2405068_CR61","first-page":"303","volume":"89","author":"I Del Giudice","year":"2004","unstructured":"Del Giudice I, Matutes E, Morilla R, Morilla A, Owusu-Ankomah K, Rafiq F et al. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. Haematologica 2004; 89: 303\u2013308.","journal-title":"Haematologica"},{"key":"BF2405068_CR62","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0140-6736(04)16356-3","volume":"363","author":"B Falini","year":"2004","unstructured":"Falini B, Tiacci E, Liso A, Basso K, Sabattini E, Pacini R et al. Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet 2004; 363: 1869\u20131870.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"BF2405068_CR63","first-page":"57","volume":"14","author":"E Matutes","year":"1994","unstructured":"Matutes E, Morilla R, Owusu-Ankomah K, Houliham A, Meeus P, Catovsky D . The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leuk Lymphoma 1994; 14 (Suppl 1): 57\u201361.","journal-title":"Leuk Lymphoma"},{"key":"BF2405068_CR64","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5858\/2005-129-395-HCLVWF","volume":"129","author":"C Ya-In","year":"2005","unstructured":"Ya-In C, Brandwein J, Pantalony D, Chang H . Hairy cell leukemia variant with features of intrasinusoidal bone marrow involvement. Arch Pathol Lab Med 2005; 129: 395\u2013398.","journal-title":"Arch Pathol Lab Med"},{"key":"BF2405068_CR65","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/(SICI)1096-8652(199604)51:4<282::AID-AJH6>3.0.CO;2-S","volume":"51","author":"T Sun","year":"1996","unstructured":"Sun T, Dittmar K, Koduru P, Susin M, Teichberg S, Brody J . Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept. Am J Hematol 1996; 51: 282\u2013288.","journal-title":"Am J Hematol"},{"key":"BF2405068_CR66","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.leu.2401999","volume":"15","author":"E Matutes","year":"2001","unstructured":"Matutes E, Wotherspoon A, Brito-Babapulle V, Catovsky D . The natural history and clinico-pathological features of the variant form of hairy cell leukemia. Leukemia 2001; 15: 184\u2013186.","journal-title":"Leukemia"},{"key":"BF2405068_CR67","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2141.1991.tb04417.x","volume":"78","author":"SP Mulligan","year":"1991","unstructured":"Mulligan SP, Matutes E, Dearden C, Catovsky D . Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases. Br J Haematol 1991; 78: 206\u2013209.","journal-title":"Br J Haematol"},{"key":"BF2405068_CR68","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1365-2141.1997.3523168.x","volume":"99","author":"S Bolam","year":"1997","unstructured":"Bolam S, Orchard J, Oscier D . Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes. Br J Haematol 1997; 99: 158\u2013161.","journal-title":"Br J Haematol"},{"key":"BF2405068_CR69","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1600-0609.2002.02759.x","volume":"69","author":"M Yasukawa","year":"2002","unstructured":"Yasukawa M, Yamauchi H, Azuma T, Takada K, Ishimura M, Fujita S . Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes. Eur J Haematol 2002; 69: 112\u2013114.","journal-title":"Eur J Haematol"},{"key":"BF2405068_CR70","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/sj.leu.2401710","volume":"14","author":"F Lefrere","year":"2000","unstructured":"Lefrere F, Hermine O, Belanger C, Francois S, Tilly H, Lebas de La Cour JC et al. Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes. Leukemia 2000; 14: 573\u2013575.","journal-title":"Leukemia"},{"key":"BF2405068_CR71","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hon.717","volume":"21","author":"R Riccioni","year":"2003","unstructured":"Riccioni R, Caracciolo F, Galimberti S, Cecconi N, Petrini M . Low dose 2-CdA schedule activity in splenic marginal zone lymphomas. Hematol Oncol 2003; 21: 163\u2013168.","journal-title":"Hematol Oncol"},{"key":"BF2405068_CR72","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1600-0609.2005.00426.x","volume":"75","author":"E Iannitto","year":"2005","unstructured":"Iannitto E, Minardi V, Calvaruso G, Ammatuna E, Florena AM, Mule A et al. Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes. Eur J Haematol 2005; 75: 130\u2013135.","journal-title":"Eur J Haematol"},{"key":"BF2405068_CR73","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3816\/CLM.2006.n.033","volume":"6","author":"A Fabbri","year":"2006","unstructured":"Fabbri A, Gozzetti A, Lazzi S, Lenoci M, D'Amuri A, Leoncini L et al. Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia. Clin Lymphoma Myeloma 2006; 6: 496\u2013499.","journal-title":"Clin Lymphoma Myeloma"},{"key":"BF2405068_CR74","first-page":"856","volume":"90","author":"M Bennett","year":"2005","unstructured":"Bennett M, Sharma K, Yegena S, Gavish I, Dave HP, Schechter GP . Rituximab monotherapy for splenic marginal zone lymphoma. Haematologica 2005; 90: 856\u2013858.","journal-title":"Haematologica"},{"key":"BF2405068_CR75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cncr.21931","volume":"107","author":"AM Tsimberidou","year":"2006","unstructured":"Tsimberidou AM, Catovsky D, Schlette E, O'Brien S, Wierda WG, Kantarjian H et al. Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone. Cancer 2006; 107: 125\u2013135.","journal-title":"Cancer"},{"key":"BF2405068_CR76","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hon.820","volume":"25","author":"C Kalpadakis","year":"2007","unstructured":"Kalpadakis C, Pangalis GA, Dimopoulou MN, Vassilakopoulos TP, Kyrtsonis MC, Korkolopoulou P et al. Rituximab monotherapy is highly effective in splenic marginal zone lymphoma. Hematol Oncol 2007; 25: 127\u2013131.","journal-title":"Hematol Oncol"},{"key":"BF2405068_CR77","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","volume":"347","author":"O Hermine","year":"2002","unstructured":"Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 89\u201394.","journal-title":"N Engl J Med"},{"key":"BF2405068_CR78","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/sj.leu.2403443","volume":"18","author":"C Kelaidi","year":"2004","unstructured":"Kelaidi C, Rollot F, Park S, Tulliez M, Christoforov B, Calmus Y et al. Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas. Leukemia 2004; 18: 1711\u20131716.","journal-title":"Leukemia"},{"key":"BF2405068_CR79","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00000478-200110000-00007","volume":"25","author":"FI Camacho","year":"2001","unstructured":"Camacho FI, Mollejo M, Mateo MS, Algara P, Navas C, Hernandez JM et al. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases. Am J Surg Pathol 2001; 25: 1268\u20131276.","journal-title":"Am J Surg Pathol"},{"key":"BF2405068_CR80","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2004-10-3898","volume":"106","author":"E Ruiz-Ballesteros","year":"2005","unstructured":"Ruiz-Ballesteros E, Mollejo M, Rodriguez A, Camacho FI, Algara P, Martinez N et al. Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. Blood 2005; 106: 1831\u20131838.","journal-title":"Blood"},{"key":"BF2405068_CR81","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/hep.1840360702","volume":"36","author":"LB Seeff","year":"2002","unstructured":"Seeff LB, Hoofnagle JH . National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002. Hepatology 2002; 36: S1\u2013S2.","journal-title":"Hepatology"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2405068.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2405068","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2405068.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T08:01:45Z","timestamp":1737705705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2405068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,20]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["BF2405068"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2405068","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,20]]},"assertion":[{"value":"28 September 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}